Glycemic Control – Medxy AI

Low-Carbohydrate Diets, Nutritional Adequacy, Glycemia, and Perinatal Outcomes in Women With Gestational Diabetes Mellitus: Insights from the DiGest Trial and Contemporary Evidence

By MedXY 10/28/2026

This review synthesizes current evidence on low-carbohydrate diets in gestational diabetes mellitus (GDM), highlighting effects on glycemia, nutrient adequacy, and perinatal outcomes from the DiGest trial and supporting literature.

Cardiology Diabetes & Endocrinology news

A Recipe for Better Diabetes Management: Embracing the DASH4D Dietary Pattern

By MedXY 10/27/2026

The DASH4D diet, a diabetes-adapted version of the DASH eating plan, significantly improves blood pressure and blood sugar control in type 2 diabetes with hypertension, offering a strong evidence-based dietary recommendation for personalized nutrition therapy.

Diabetes & Endocrinology Internal Medicine news

Enhancing Glycemic Control in Non-Insulin-Treated Type 2 Diabetes with Continuous Glucose Monitoring: New Evidence from the CONNECT Trial

By MedXY 10/24/2026

The CONNECT trial demonstrates that continuous glucose monitoring (CGM) significantly improves glycemic control in adults with non-insulin-treated type 2 diabetes managed in primary care, reducing HbA1c levels and hyperglycemia risk without increasing hypoglycemia.

Clinical Updates Diabetes & Endocrinology news

Efficacy and Safety of the twiist Automated Insulin Delivery System in Insulin-Treated Type 2 Diabetes: A Comprehensive Review of the twiist-T2D Pivotal Trial and Related Evidence

By MedXY 10/16/2026

The twiist AID system significantly improves glycemic control and patient satisfaction in insulin-treated type 2 diabetes over 13 weeks, demonstrating safety and effectiveness supported by complementary real-world and RCT data.

Diabetes & Endocrinology news

Retatrutide: A Breakthrough Triple Agonist for Obesity and Type 2 Diabetes Management

By MedXY 10/15/2026

Retatrutide, a triple agonist targeting GIP, GLP-1, and glucagon receptors, significantly reduces bodyweight and improves glycemic control in adults with obesity and type 2 diabetes, showing promising efficacy and a manageable safety profile in the phase 3 TRIUMPH-2 trial.

Diabetes & Endocrinology Gastroenterology news

Optimizing Insulin Therapy with Continuous Glucose Monitoring in Nocturnal Parenteral Nutrition Patients

By MedXY 10/15/2026

Continuous glucose monitoring-guided insulin optimization improves glycemic control and nutritional status in insulin-treated adults receiving long-term nocturnal parenteral nutrition, reducing hyperglycemia and associated complications.

Diabetes & Endocrinology news Pediatrics

Impact of School Care Locations on Glycemic Control in Children with Type 1 Diabetes: Insights from a Japanese Multicenter Study

By MedXY 10/13/2026

This study explores how the choice of diabetes self-care location at school affects glycemic control in children with Type 1 diabetes, highlighting restroom use as a risk factor for poorer outcomes and emphasizing the need for supportive school environments.

Diabetes & Endocrinology news Pediatrics

Behavioral Interventions in Pediatric Type 1 Diabetes: Optimizing Glycemic Control Through Family-Centered, Multicomponent Strategies

By MedXY 10/02/2026

Updated meta-analysis reveals modest HbA1C improvements with behavioral interventions in youth with type 1 diabetes, highlighting the superiority of family-focused, multicomponent approaches over single-focus programs.

Diabetes & Endocrinology news

Longitudinal Glycemic Trajectories in Adults with Type 1 Diabetes: Insights from a Three-Year Multicenter CGM Study

By MedXY 09/21/2026

This study investigates three-year continuous glucose monitoring trajectories across clinical subgroups of adults with type 1 diabetes to identify factors influencing glycemic control and variability, highlighting the need for individualized management based on CGM data.

Diabetes & Endocrinology Internal Medicine news

Impact of the DASH4D Diet on Glycemic Biomarkers in Adults with Type 2 Diabetes: Insights from a Randomized Controlled Feeding Trial

By MedXY 08/30/2026

The DASH4D diet, a tailored DASH-style intervention for diabetes, significantly improved key glycemic biomarkers including fructosamine, fasting glucose, and HbA1c compared to a typical American diet in adults with type 2 diabetes.

Diabetes & Endocrinology news

HTD1801 Monotherapy Significantly Improves Glycemic Control and Cardiometabolic Health in Type 2 Diabetes: Results From a 56-Week Phase 3 Trial

By MedXY 08/25/2026

A phase 3 trial demonstrated that HTD1801 monotherapy significantly reduces HbA1c and improves cardiometabolic and inflammatory markers in patients with inadequately controlled type 2 diabetes, with sustained effects and a favorable safety profile over 56 weeks.

Clinical Updates Diabetes & Endocrinology news

Glucose in Motion: Insights into Temporal Patterns of Glycemic Control in Real-World Diabetes Management

By MedXY 08/18/2026

This review synthesizes evidence on daily and weekly patterns of glycemic control in real-world CGM data, highlighting small but consistent temporal variations that inform personalized diabetes care.

Diabetes & Endocrinology news

Time-Restricted Eating in Adults With Type 1 Diabetes: Safety and Glycemic Benefits Without Significant Weight Loss

By MedXY 08/17/2026

A 6-month randomized controlled trial found that time-restricted eating (TRE) in adults with type 1 diabetes is safe and improves HbA1c levels but does not significantly reduce body weight compared to calorie restriction or no intervention.

Diabetes & Endocrinology news

Impact of Residual C-Peptide on Long-Term Outcomes in Type 1 Diabetes: Insights from the Scottish Cohort

By MedXY 08/11/2026

This study highlights that higher baseline and maintained C-peptide levels in type 1 diabetes are linked to reduced risks of acute complications and retinopathy, underscoring the importance of preserving endogenous insulin secretion.

Diabetes & Endocrinology Gastroenterology news

EndoBarrier Duodenal-Jejunal Bypass Liner: A Novel Endoscopic Adjunct for Improved Glycemic Control and Weight Loss in Type 2 Diabetes with Obesity

By MedXY 07/15/2026

The ENDO trial demonstrates that the EndoBarrier duodenal-jejunal bypass liner significantly improves glycemic control and induces meaningful weight loss in patients with poorly controlled type 2 diabetes and obesity, with an acceptable safety profile.

Diabetes & Endocrinology Internal Medicine news

Evaluating Sleep Optimization for Glycemic Control in Adults with Type 1 Diabetes: Insights from a Randomized Controlled Trial

By MedXY 07/03/2026

A 12-week randomized trial explored sleep optimization in adults with type 1 diabetes, revealing improved sleep quality and reduced diabetes distress but limited glycemic benefits except in patients with baseline A1C ≥7%.

Diabetes & Endocrinology news

Semaglutide as an Effective Add-On Therapy in Latent Autoimmune Diabetes in Adults: Enhancing Glycemic Control and Preserving β-Cell Function

By MedXY 06/27/2026

This study evaluates the clinical benefits of semaglutide, a GLP-1 receptor agonist, as an add-on therapy to insulin in patients with LADA, demonstrating improved glycemic control, BMI reduction, and insulin dose sparing, especially in those with preserved β-cell function.

Diabetes & Endocrinology Gastroenterology news

Glycemic Control and Diabetes Outcomes After Surgical Therapy for Diabetic Gastroparesis

By MedXY 05/29/2026

Surgical therapy for diabetic gastroparesis was linked to better long-term HbA1c control, less insulin use, and fewer diabetes-related complications, though mortality was unchanged.

Diabetes & Endocrinology news

Real-Time CGM Outperforms SMBG in Glycemic Control for Type 2 Diabetes on Basal Insulin Plus Modern Therapies

By MedXY 04/29/2026

The FreeDM2 trial demonstrates that real-time CGM significantly improves HbA1c levels compared to SMBG in adults with type 2 diabetes on basal insulin and modern therapies, with sustained benefits over 32 weeks.

Diabetes & Endocrinology news

Exercise Snacks Improve Glycemic Control in Type 2 Diabetes: A Real-World Randomized Crossover Study

By MedXY 04/28/2026

A study demonstrates that short bursts of vigorous bodyweight exercise reduce postprandial hyperglycemia and glycemic variability in individuals with type 2 diabetes, offering a practical intervention for glucose management.